CVS blows past estimates, hikes guidance as insurance unit continues to improve

CVS Health exceeded expectations in its second-quarter earnings and projected revenue, as its insurance unit Aetna showed signs of improvement. The company now anticipates full-year adjusted earnings between $7.90 and $8.10 per share, an increase from the previous range of $7.30 to $7.50 per share. Additionally, CVS expects at least $414 billion in revenue for 2026, surpassing its earlier prediction of $405 billion.

The higher profit guidance is attributed to gains in the company's insurance and retail pharmacy divisions, although CVS maintains a "cautious view" for the subsequent quarters due to high medical costs and potential economic challenges.

CVS' insurance business, Aetna, demonstrated a positive trend with a medical benefit ratio of 87.4% in the second quarter, down from 89.9% in the previous year. This reduction signifies that the company collected more premiums than it paid out in benefits, resulting in increased profitability. The unit's revenue grew by 3.5% year-over-year to $37.54 billion, exceeding analysts' expectations of $35.66 billion. Aetna's medical membership remained steady at 26 million as of June 30, closely aligning with the March 31 figure.

CVS' pharmacy and consumer wellness division reported $33.82 billion in revenue for the quarter, slightly higher than the prior year's $33.16 billion. Analysts had anticipated sales of $33.16 billion. The health services segment generated $51.8 billion in revenue for the quarter, an 11.5% increase compared to the same period last year. This segment encompasses the pharmacy benefits manager Caremark, which negotiates drug discounts, manages formularies, and reimburses pharmacies for prescriptions.